Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.
about
Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesisEfficacy of ampicillin against methicillin-resistant Staphylococcus aureus restored through synergy with branched poly(ethylenimine)Optimizing glycosyltransferase specificity via "hot spot" saturation mutagenesis presents a catalyst for novobiocin glycorandomization.A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinasesHigh throughput discovery of heteroaromatic-modifying enzymes allows enhancement of novobiocin selectivity.Mannich reaction derivatives of novobiocin with modulated physiochemical properties and their antibacterial activitiesA comprehensive review of glycosylated bacterial natural products.Biological activities of novel gyrase inhibitors of the aminocoumarin classMutasynthesis, chemobiosynthesis, and back to semi-synthesis: combining synthetic chemistry and biosynthetic engineering for diversifying natural products.Novel Zinc(II) Complexes of Heterocyclic Ligands as Antimicrobial Agents: Synthesis, Characterisation, and Antimicrobial Studies.Enzymatic basis of "hybridity" in thiomarinol biosynthesisSynthesis and Biological Evaluation of New Hydrazone Derivatives of Quinoline and Their Cu(II) and Zn(II) Complexes against Mycobacterium tuberculosis.Tricyclic sesquiterpenes from Vetiveria zizanoides (L.) Nash as antimycobacterial agents.Phylogenetics of an antibiotic producing Streptomyces strain isolated from soil.Insight into the structure-function relationship of the nonheme iron halogenases involved in the biosynthesis of 4-chlorothreonine --Thr3 from Streptomyces sp. OH-5093 and SyrB2 from Pseudomonas syringae pv. syringae B301DR.Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
P2860
Q24542413-EA8D7C3D-E9CE-48B8-A162-5B19FD0AB6A8Q28821040-4F7005F4-12A4-45C7-856E-C7AD3D0C9FABQ33620516-B38EEC7F-9F30-42F0-AB62-F28272432D30Q33738068-81A8B0F5-1EDF-4FD0-A680-2B4367CDF576Q34001563-2579CBA1-5B97-4E52-A066-C2683AFDBA3FQ35227070-226120ED-4AE0-4365-9EC5-F7DF51448A15Q36029831-BBAA1AF3-C568-4E63-B0E8-EAD9D18F0777Q36702934-FFF9423E-19C3-4206-9473-FA7C17C0B12AQ37077332-138FB4D1-1CBF-4028-A641-563A027CB368Q38269367-795379C9-3481-4DA6-BDE7-DD6E6D7B46CCQ41845672-6E867405-DEB2-4C70-A91F-5AF9870FF20AQ42112653-5762CDF2-257B-42A3-9F88-70BB47E882D6Q42710319-EB2B4C8D-59CC-4732-84C8-F063DCB452DBQ42914122-13ABA1F3-4EF9-4AFC-9ADA-62B17FC62A44Q46589142-8FDEAEC6-80C0-491A-924F-A6902CC42395Q54358881-BF97B11D-BD78-43E0-99B7-CF09CFD47E5F
P2860
Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimicrobial and DNA gyrase-i ...... ves produced by mutasynthesis.
@en
Antimicrobial and DNA gyrase-i ...... ves produced by mutasynthesis.
@nl
type
label
Antimicrobial and DNA gyrase-i ...... ves produced by mutasynthesis.
@en
Antimicrobial and DNA gyrase-i ...... ves produced by mutasynthesis.
@nl
prefLabel
Antimicrobial and DNA gyrase-i ...... ves produced by mutasynthesis.
@en
Antimicrobial and DNA gyrase-i ...... ves produced by mutasynthesis.
@nl
P2093
P2860
P1476
Antimicrobial and DNA gyrase-i ...... ives produced by mutasynthesis
@en
P2093
Malcolm Page
Shu-Ming Li
Stefanie Heller
Stuart Shapiro
P2860
P304
P356
10.1128/AAC.48.4.1307-1312.2004
P407
P50
P577
2004-04-01T00:00:00Z